Traumatic Proximal Femoral Fractures during COVID-19 Pandemic in the US: An ACS NSQIP ® Analysis.

In order to determine the impact of COVID-19 on the treatment and outcomes in patients with proximal femoral fracture's (PFF), we analyzed a national US sample. This is a retrospective review of American College of Surgery's (ACS) National Surgical Quality Improvement Program (NSQIP) for patients with proximal femoral fractures. A total of 26,830 and 26,300 patients sustaining PFF and undergoing surgical treatment were sampled during 2019 and 2020, respectively. On multivariable logistic regression, patients were less likely to have 'presence of non-healing wound' ( p < 0.001), functional status 'independent' ( p = 0.012), undergo surgical procedures of 'hemiarthroplasty'( p = 0.002) and 'ORIF IT, Peritroch, Subtroch with plates and screws' ( p < 0.001) and to be 'alive at 30-days post-op' ( p = 0.001) in 2020 as compared to 2019. Patients were more likely to have a case status 'emergent', 'loss of ≥10% body weight', discharge destination of 'home' ( p < 0.001 for each) or 'leaving against medical advice' ( p = 0.026), postoperative 'acute renal failure (ARF)' ( p = 0.011), 'myocardial infarction (MI)' ( p = 0.006), 'pulmonary embolism (PE)' ( p = 0.047), and 'deep venous thrombosis (DVT)' ( p = 0.049) in 2020 as compared to 2019. Patients sustaining PFF and undergoing surgical treatment during pandemic year 2020 differed significantly in preoperative characteristics and 30-day postoperative complications when compared to patients from the previous year.